Table 8.
Presence and geometric mean titres of antibodies against human papillomaviruses in CML patients prior to the start of the therapy and after achieving hematological and/or complete cytogenetic remission.
antibody presence | |||||||
---|---|---|---|---|---|---|---|
Sample | No. | HPV6 | HPV11 | HPV16 | HPV18 | HPV31 | HPV33 |
| |||||||
First | 11 | 6 | 5 | 3 | 3 | 3 | 1 |
Last | 11 | 5 | 3 | 3 | 3 | 2 | 1 |
| |||||||
GMT | |||||||
| |||||||
First | 11 | 1.27 | 1.01 | 0.68 | 1.00 | 0.79 | 0.50 |
Last | 11 | 1.08 | 0.88 | 0.65 | 0.75 | 0.61 | 0.38 |